share_log

Cantor Fitzgerald Initiates Coverage On Structure Therapeutics With Overweight Rating, Announces Price Target of $65

Cantor Fitzgerald Initiates Coverage On Structure Therapeutics With Overweight Rating, Announces Price Target of $65

坎托·菲茨杰拉德以增持评级启动对结构疗法的报道,宣布目标股价为65美元
Moomoo 24/7 ·  04/09 07:03

Cantor Fitzgerald analyst Prakhar Agrawal initiates coverage on Structure Therapeutics (NASDAQ:GPCR) with a Overweight rating and announces Price Target of $65.

坎托·菲茨杰拉德分析师普拉哈尔·阿格劳瓦尔以增持评级开始对Structure Therapeutics(纳斯达克股票代码:GPCR)进行报道,并宣布目标股价为65美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发